SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-125149
Filing Date
2019-04-29
Accepted
2019-04-29 16:06:04
Documents
2
Period of Report
2019-06-18
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d644795ddef14a.htm DEF 14A 865769
2 GRAPHIC g644795g45a81.jpg GRAPHIC 32310
  Complete submission text file 0001193125-19-125149.txt   911356
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37539 | Film No.: 19775899
SIC: 2834 Pharmaceutical Preparations